BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29064485)

  • 1. Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia: results of the EORTC CLG 58881 and 58951 trials.
    Piette C; Suciu S; Clappier E; Bertrand Y; Drunat S; Girard S; Yakouben K; Plat G; Dastugue N; Mazingue F; Grardel N; van Roy N; Uyttebroeck A; Costa V; Minckes O; Sirvent N; Simon P; Lutz P; Ferster A; Pluchart C; Poirée M; Freycon C; Dresse MF; Millot F; Chantrain C; van der Werff Ten Bosch J; Norga K; Gilotay C; Rohrlich PS; Benoit Y; Cavé H
    Leukemia; 2018 Jan; 32(1):244-248. PubMed ID: 29064485
    [No Abstract]   [Full Text] [Related]  

  • 2. RAG1 co-expression signature identifies ETV6-RUNX1-like B-cell precursor acute lymphoblastic leukemia in children.
    Chen D; Camponeschi A; Nordlund J; Marincevic-Zuniga Y; Abrahamsson J; Lönnerholm G; Fogelstrand L; Mårtensson IL
    Cancer Med; 2021 Jun; 10(12):3997-4003. PubMed ID: 33987955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy inhibition as a potential future targeted therapy for ETV6-RUNX1-driven B-cell precursor acute lymphoblastic leukemia.
    Polak R; Bierings MB; van der Leije CS; Sanders MA; Roovers O; Marchante JRM; Boer JM; Cornelissen JJ; Pieters R; den Boer ML; Buitenhuis M
    Haematologica; 2019 Apr; 104(4):738-748. PubMed ID: 30381299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discontinuation of L-asparaginase and poor response to prednisolone are associated with poor outcome of ETV6-RUNX1-positive pediatric B-cell precursor acute lymphoblastic leukemia.
    Usami I; Imamura T; Takahashi Y; Suenobu SI; Hasegawa D; Hashii Y; Deguchi T; Hori T; Shimada A; Kato K; Ito E; Moriya-Saito A; Kawasaki H; Hori H; Yumura-Yagi K; Hara J; Sato A; Horibe K;
    Int J Hematol; 2019 Apr; 109(4):477-482. PubMed ID: 30689137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor suppressor BTG1 limits activation of BCL6 expression downstream of ETV6-RUNX1.
    Tijchon E; van Emst L; Yuniati L; van Ingen Schenau D; Gerritsen M; van der Meer LT; Williams O; Hoogerbrugge PM; Scheijen B; van Leeuwen FN
    Exp Hematol; 2018 Apr; 60():57-62.e3. PubMed ID: 29408281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ETV6/RUNX1-positive childhood acute lymphoblastic leukemia (ALL): The spectrum of clonal heterogeneity and its impact on prognosis.
    Ampatzidou M; Papadhimitriou SI; Paterakis G; Pavlidis D; Tsitsikas Κ; Kostopoulos IV; Papadakis V; Vassilopoulos G; Polychronopoulou S
    Cancer Genet; 2018 Aug; 224-225():1-11. PubMed ID: 29778230
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Montaño A; Ordoñez JL; Alonso-Pérez V; Hernández-Sánchez J; Santos S; González T; Benito R; García-Tuñón I; Hernández-Rivas JM
    Cells; 2020 Jan; 9(1):. PubMed ID: 31952221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Double Negative Loop Comprising ETV6/RUNX1 and MIR181A1 Contributes to Differentiation Block in t(12;21)-Positive Acute Lymphoblastic Leukemia.
    Yang YL; Yen CT; Pai CH; Chen HY; Yu SL; Lin CY; Hu CY; Jou ST; Lin DT; Lin SR; Lin SW
    PLoS One; 2015; 10(11):e0142863. PubMed ID: 26580398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of ETV6-RUNX1 fusion gene in children with acute lymphoblastic leukemia in China.
    Gao YJ; Zhu XH; Yang Y; Wu Y; Lu FJ; Zhai XW; Wang HS
    Cancer Genet Cytogenet; 2007 Oct; 178(1):57-60. PubMed ID: 17889709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RUNX1 aberrations in ETV6/RUNX1-positive and ETV6/RUNX1-negative patients: its hemato-pathological and prognostic significance in a large cohort (619 cases) of ALL.
    Pais AP; Amare Kadam PS; Raje GC; Banavali S; Parikh P; Kurkure P; Arora B; Gujral S; Kumar SA; Badrinath Y
    Pediatr Hematol Oncol; 2008 Sep; 25(6):582-97. PubMed ID: 18728978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SYK Targeting Represents a Potential Therapeutic Option for Relapsed Resistant Pediatric
    Serafin V; Porcù E; Cortese G; Mariotto E; Veltri G; Bresolin S; Basso G; Accordi B
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous occurrence of ETV6-RUNX1 and BCR-ABL1 (e1a2) transcripts in a child with B-cell acute lymphoblastic leukemia.
    Balatzenko G; Guenova M; Kalinova I; Belcheva M; Hristozova H; Kaleva V
    Cancer Genet; 2013 Mar; 206(3):97-101. PubMed ID: 23491079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ETV6/RUNX1-positive childhood acute lymphoblastic leukemia in China: excellent prognosis with improved BFM protocol.
    Wang Y; Zeng HM; Zhang LP
    Ital J Pediatr; 2018 Aug; 44(1):94. PubMed ID: 30115129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel ETV6-RUNX1 Mouse Model to Study the Role of ELF-MF in Childhood B-Acute Lymphoblastic Leukemia: a Pilot Study.
    Campos-Sanchez E; Vicente-Dueñas C; Rodríguez-Hernández G; Capstick M; Kuster N; Dasenbrock C; Sánchez-García I; Cobaleda C
    Bioelectromagnetics; 2019 Jul; 40(5):343-353. PubMed ID: 31157932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The gene expression level of m6A catalytic enzymes is increased in ETV6/RUNX1-positive acute lymphoblastic leukemia.
    Wang Y; Zeng HM; Xue YJ; Lu AD; Jia YP; Zuo YX; Zhang LP
    Int J Lab Hematol; 2021 Apr; 43(2):e89-e91. PubMed ID: 33170547
    [No Abstract]   [Full Text] [Related]  

  • 16. Reduction of RUNX1 transcription factor activity by a CBFA2T3-mimicking peptide: application to B cell precursor acute lymphoblastic leukemia.
    Jakobczyk H; Debaize L; Soubise B; Avner S; Rouger-Gaudichon J; Commet S; Jiang Y; Sérandour AA; Rio AG; Carroll JS; Wichmann C; Lie-A-Ling M; Lacaud G; Corcos L; Salbert G; Galibert MD; Gandemer V; Troadec MB
    J Hematol Oncol; 2021 Mar; 14(1):47. PubMed ID: 33743795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infection Exposure Promotes
    Rodríguez-Hernández G; Hauer J; Martín-Lorenzo A; Schäfer D; Bartenhagen C; García-Ramírez I; Auer F; González-Herrero I; Ruiz-Roca L; Gombert M; Okpanyi V; Fischer U; Chen C; Dugas M; Bhatia S; Linka RM; Garcia-Suquia M; Rascón-Trincado MV; Garcia-Sanchez A; Blanco O; García-Cenador MB; García-Criado FJ; Cobaleda C; Alonso-López D; De Las Rivas J; Müschen M; Vicente-Dueñas C; Sánchez-García I; Borkhardt A
    Cancer Res; 2017 Aug; 77(16):4365-4377. PubMed ID: 28630052
    [No Abstract]   [Full Text] [Related]  

  • 18. Prognostic impact of RUNX1 and ETV6 gene copy number on pediatric B-cell precursor acute lymphoblastic leukemia with or without hyperdiploidy.
    Kutlay NY; Pekpak E; Altıner S; Ileri T; Vicdan AN; Dinçaslan H; Ince EU; Tukun FA
    Int J Hematol; 2016 Sep; 104(3):368-77. PubMed ID: 27393278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Siblings with ETV6/RUNX1-positive B-lymphoblastic leukemia: A single site experience and review of the literature.
    Martig DS; Williamson CM; Xu X; Sukov WR; Greipp PT; Hoppman NL; Baughn LB; Ketterling RP; Peterson JF
    Ann Diagn Pathol; 2020 Oct; 48():151588. PubMed ID: 32836179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Near-tetraploidy in childhood B-cell precursor acute lymphoblastic leukemia is a highly specific feature of ETV6/RUNX1-positive leukemic cases.
    Attarbaschi A; Mann G; König M; Steiner M; Dworzak MN; Gadner H; Haas OA;
    Genes Chromosomes Cancer; 2006 Jun; 45(6):608-11. PubMed ID: 16552772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.